Skip to content

Devaluation and Revaluation as Dynamic Social Processes: The Case of Psychedelic Stigma.

Hannah Farrimond, Mike Michael

Sociology of Health & Illness May 1, 2026 DOI: 10.1111/1467-9566.70200 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Theoretical or philosophical paper Case report Peer reviewed
Keywords Drugs Legalisation Prejudice Psychedelics Social processes Stigma trajectories Stigmatisation
Key points Proposes that psychedelic drug stigma is undergoing social 'revaluation' due to drivers such as Western biomedicine's interest in psychedelics as therapeutics.

Abstract

Stigma is a form of social devaluation, eliciting shame, disgust and othering. Most theorisation of stigma has focused on devaluation and stigmatisation; this paper identifies and expands on the concept of 'revaluation', defined as the positive revision of previously derogated social objects as part of ongoing stigma trajectories. To do so, we draw on 'stigma mutation' theory, which highlights three dynamic dimensions of stigma change over time: the lineage or history of the stigma, its variation in diverse groups and contexts and its intensity or strength. We further draw on assemblage theories to explain the dynamism of stigma trajectories where both established and novel connections occur globally and locally beyond traditional group or identity boundaries. To illustrate the processes of revaluation, we present a case study of psychedelic drug stigma, analysing academic texts and media articles. Although psychedelic stigma has embedded lineage within existing illegal drug stigma, it is undergoing social revaluation due to other drivers, such as Western biomedicine's recent interest in psychedelics as therapeutics. It is important to consider the dynamism of devaluation and revaluation processes within stigma trajectories; these may occur simultaneously, in complex ways, as the result of multiple connections in both local and global worlds.

Citations in the library